505 related articles for article (PubMed ID: 31313503)
1. Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus.
van Dam LS; Kraaij T; Kamerling SWA; Bakker JA; Scherer UH; Rabelink TJ; van Kooten C; Teng YKO
Arthritis Rheumatol; 2019 Dec; 71(12):2047-2058. PubMed ID: 31313503
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases.
van Dam LS; Rabelink TJ; van Kooten C; Teng YKO
Kidney Int Rep; 2019 Feb; 4(2):196-211. PubMed ID: 30775617
[TBL] [Abstract][Full Text] [Related]
3. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
Huang YM; Wang H; Wang C; Chen M; Zhao MH
Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
[TBL] [Abstract][Full Text] [Related]
5. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
[TBL] [Abstract][Full Text] [Related]
6. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Barnado A; Crofford LJ; Oates JC
J Leukoc Biol; 2016 Feb; 99(2):265-78. PubMed ID: 26658004
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil extracellular traps in vasculitis, friend or foe?
Söderberg D; Segelmark M
Curr Opin Rheumatol; 2018 Jan; 30(1):16-23. PubMed ID: 28957962
[TBL] [Abstract][Full Text] [Related]
8. Involvement of neutrophil extracellular traps in the pathogenesis of glomerulonephritis in a case of systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome.
Senda A; Sasai R; Kato K; Nishibata Y; Masuda S; Ishizu A; Takahara N
CEN Case Rep; 2022 Aug; 11(3):339-346. PubMed ID: 35025058
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
10. Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus.
Van Avondt K; Fritsch-Stork R; Derksen RH; Meyaard L
PLoS One; 2013; 8(10):e78459. PubMed ID: 24205237
[TBL] [Abstract][Full Text] [Related]
11. Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus.
Chapman EA; Lyon M; Simpson D; Mason D; Beynon RJ; Moots RJ; Wright HL
Front Immunol; 2019; 10():423. PubMed ID: 30915077
[TBL] [Abstract][Full Text] [Related]
12. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
[TBL] [Abstract][Full Text] [Related]
13. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps.
Dwivedi N; Upadhyay J; Neeli I; Khan S; Pattanaik D; Myers L; Kirou KA; Hellmich B; Knuckley B; Thompson PR; Crow MK; Mikuls TR; Csernok E; Radic M
Arthritis Rheum; 2012 Apr; 64(4):982-92. PubMed ID: 22034172
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of citrullinated histone H3-positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody-associated vasculitis.
Kimura H; Mii A; Shoji J; Arakawa Y; Shimizu A
Histopathology; 2021 Mar; 78(4):520-531. PubMed ID: 32956514
[TBL] [Abstract][Full Text] [Related]
15. An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment.
Frangou E; Vassilopoulos D; Boletis J; Boumpas DT
Autoimmun Rev; 2019 Aug; 18(8):751-760. PubMed ID: 31181324
[TBL] [Abstract][Full Text] [Related]
16. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
[TBL] [Abstract][Full Text] [Related]
17. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.
Takeda S; Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Nishio S; Atsumi T
Front Immunol; 2019; 10():1334. PubMed ID: 31249574
[No Abstract] [Full Text] [Related]
18. The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps.
Antiochos B; Trejo-Zambrano D; Fenaroli P; Rosenberg A; Baer A; Garg A; Sohn J; Li J; Petri M; Goldman DW; Mecoli C; Casciola-Rosen L; Rosen A
Elife; 2022 May; 11():. PubMed ID: 35608258
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
Ueda Y; Nakazawa D; Nishio S; Shiratori-Aso S; Kudo T; Miyoshi-Harashima A; Watanabe-Kusunoki K; Hattanda F; Iwasaki S; Tsuji T; Tomaru U; Aratani Y; Yamamoto M; Ishizu A; Atsumi T
Kidney Int; 2024 Jun; 105(6):1291-1305. PubMed ID: 38537677
[TBL] [Abstract][Full Text] [Related]
20. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
Kraaij T; Kamerling SWA; de Rooij ENM; van Daele PLA; Bredewold OW; Bakker JA; Bajema IM; Scherer HU; Toes REM; Huizinga TJW; Rabelink TJ; van Kooten C; Teng YKO
J Autoimmun; 2018 Jul; 91():45-54. PubMed ID: 29636274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
